Bicycle Therapeutics Files 8-K Report
Ticker: BCYC · Form: 8-K · Filed: Oct 23, 2024 · CIK: 1761612
Sentiment: neutral
Topics: sec-filing, 8-k, financials
Related Tickers: BCYC
TL;DR
Bicycle Therapeutics filed an 8-K today, expect updates on financials and other events.
AI Summary
On October 23, 2024, Bicycle Therapeutics plc filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. Specific details regarding new events or financial figures are not elaborated in the provided header information.
Why It Matters
This filing signals that Bicycle Therapeutics plc has made a significant disclosure to the SEC, potentially impacting investor understanding of the company's current status and future outlook.
Risk Assessment
Risk Level: low — The filing is a standard 8-K, indicating routine disclosure rather than an immediate, high-impact event.
Key Players & Entities
- Bicycle Therapeutics plc (company) — Registrant
- 001-38916 (company) — SEC File Number
- October 23, 2024 (date) — Date of Report
FAQ
What specific "Other Events" are being reported by Bicycle Therapeutics plc in this 8-K filing?
The provided header information for the 8-K filing does not specify the details of the "Other Events" being reported.
What is the significance of the "Financial Statements and Exhibits" being included in this 8-K filing?
The inclusion of "Financial Statements and Exhibits" suggests that the company is providing updated financial information or relevant supporting documents as part of this report.
When was Bicycle Therapeutics plc incorporated, and in which jurisdiction?
Bicycle Therapeutics plc was incorporated in England and Wales, as indicated by the filing.
What is the SEC file number for Bicycle Therapeutics plc?
The SEC file number for Bicycle Therapeutics plc is 001-38916.
What is the SIC code for Bicycle Therapeutics plc?
The Standard Industrial Classification (SIC) code for Bicycle Therapeutics plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 13.4 · Accepted 2024-10-23 09:01:21
Filing Documents
- tm2426653d1_8k.htm (8-K) — 30KB
- tm2426653d1_ex99-1.htm (EX-99.1) — 19KB
- tm2426653d1_ex99-1img001.jpg (GRAPHIC) — 9KB
- 0001104659-24-110749.txt ( ) — 285KB
- bcyc-20241023.xsd (EX-101.SCH) — 3KB
- bcyc-20241023_def.xml (EX-101.DEF) — 26KB
- bcyc-20241023_lab.xml (EX-101.LAB) — 36KB
- bcyc-20241023_pre.xml (EX-101.PRE) — 25KB
- tm2426653d1_8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release issued October 23, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 23, 2024 BICYCLE THERAPEUTICS PLC By: /s/ Alethia Young Name: Alethia Young Title: Chief Financial Officer